Isolation and flow cytometric analysis of T-cell-depleted CD34+PBPCs

Transfusion

Volumn 40, Issue 12, 2000, Pages 1475-1481

  Debelak, Joan ^a   Shlomchik, Mark J ^a   Snyder, Edward L ^a   Cooper, Dennis ^a   Seropian, Stuart ^a   McGuirk, Joel ^a   Smith, Brian ^a   Krause, Diane S ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE NEW HAVEN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; OKT 3; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

APHERESIS; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; FLOW CYTOMETRY; GOOD MANUFACTURING PRACTICE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; LYMPHOCYTE DEPLETION; MEDICAL INSTRUMENTATION;

ADULT; ANTIGENS, CD34; BLOOD DONORS; CELL SEPARATION; CELL TRANSPLANTATION; FEMALE; FLOW CYTOMETRY; GRAFT REJECTION; GRAFT SURVIVAL; GRAFT VS HOST DISEASE; HUMANS; LEUKAPHERESIS; LYMPHOCYTE DEPLETION; MALE; STEM CELLS; T-LYMPHOCYTES;

EID: 0034521641     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.2000.40121475.x     Document Type: Article

References (20)

1. Changing trends in marrow transplantation for aplastic anemia
2. Therapy of chronic myelogenous leukemia with allogeneic bone marrow transplantation
3. Indications for marrow transplantation in chronic myelogenous leukemia
4. Reconstitution in severe combined immunodeficiency by transplantation of marrow from an unrelated donor
5. Bone marrow transplantation for severe aplastic anemia using a phenotypically HLA-identical, SB-compatible unrelated donor
6. Histocompatible unrelated volunteer donors compared with HLA non-identical family donors in marrow transplantation for aplastic anemia and leukemia
7. Allogeneic marrow grafting with partially mismatched, unrelated donors
8. Marrow transplantation from related donors other than HLA-identical siblings
9. Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma
10. Effect of T-cell depletion as graff-versus-host disease prophylaxis on engraffment, relapse, and disease-free survival in unrelated marrow transplantation for chronic myelogenous leukemia
11. Selective depletion of CD8+ T lymphocytes for prevention of graft-versus-host disease after allogeneic bone marrow transplantation
12. Selective depletion of bone marrow T lymphocytes with anti-CD5 monoclonal antibodies: Effective prophylaxis for graff-versus-host disease in patients with hematological malignancies
13. CD6+ T cell-depleted allogeneic bone marrow transplantation for non-Hodgkin's lymphoma
14. Treatment of high-risk leukemia with T-cell-depleted HPCs from related donors with one fully mismatched HLA haplotype
15. Enumeration of CD34-positive hematopoietic progenitor cells by flow cytometry: Comparison of a volumetric assay and the ISHAGE gating strategy
16. The ISHAGE guidelines for CD34+ cell determination by flow cytometry. Int'l Society of Hematother and Graft Engineering
17. Autologous progenitor cell transplantation: Prior exposure to stem cell-toxic drags determines yield and engraftment of peripheral blood progenitor cell but not of bone marrow grafts
18. Allogeneic transplantation of selected CD34+ cells from peripheral blood: Experience of 62 cases using immunoadsorption or immunomagnetic technique. Spanish Group of allo-PBT
19. Ex vivo anti-CD3 antibody-activated donor T cells have a reduced ability to cause lethal murine graft-versus-host disease but retain their ability to facilitate alloengraftment